We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Teva, Sandoz Launch At-Risk Versions of Pfizer Drug

Law360 (November 29, 2005, 12:00 AM EST) -- The U.S. Food and Drug Administration has given the green light to three generic drug makers’ plans to market their own versions of Pfizer’s Zithromax antibiotic. Two of the companies have...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.